1308 PARTIAL NEPHRECTOMY FOR THE TREATMENT OF RENAL CELL CARCINOMA AND THE RISK OF END STAGE RENAL DISEASE

[1]  Antonio Finelli,et al.  The true risk of blood transfusion after nephrectomy for renal masses: a population‐based study , 2013, BJU international.

[2]  B. Lane,et al.  Surgically induced chronic kidney disease may be associated with a lower risk of progression and mortality than medical chronic kidney disease. , 2013, The Journal of urology.

[3]  M. Shlipak,et al.  Risk Factors for Esrd in Individuals with Preserved Estimated Gfr with and without Albuminuria: Results from the Kidney Early Evaluation Program (keep) , 2012 .

[4]  R. Uzzo,et al.  Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. , 2012, The Journal of urology.

[5]  M. Woodward,et al.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis , 2012, The Lancet.

[6]  A. Finelli,et al.  The emerging role of percutaneous biopsy in diagnosis and management of small renal masses , 2012, Current opinion in urology.

[7]  M. Tonelli,et al.  Lifetime risk of ESRD. , 2012, Journal of the American Society of Nephrology : JASN.

[8]  K. Chamie,et al.  Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. , 2012, The Journal of urology.

[9]  John L. Gore,et al.  Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. , 2012, JAMA.

[10]  Klaus Jeschke,et al.  Positive surgical margins after nephron-sparing surgery. , 2012, European urology.

[11]  Chirag R Parikh,et al.  Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. , 2012, Kidney international.

[12]  Sanjay G Patel,et al.  National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. , 2012, The Journal of urology.

[13]  A. Finelli,et al.  How often are patients with diabetes or hypertension being treated with partial nephrectomy for renal cell carcinoma? A population‐based analysis , 2011, BJU international.

[14]  H. Lee,et al.  Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  J. Stoltzfus,et al.  Logistic regression: a brief primer. , 2011, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[16]  Carl van Walraven,et al.  Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to Predict Mortality in a General Adult Population Cohort in Ontario, Canada , 2011, Medical care.

[17]  Osamu Ukimura,et al.  Treatment of localised renal cell carcinoma. , 2011, European urology.

[18]  P. Austin,et al.  The Mortality Risk Score and the ADG Score: Two Points-Based Scoring Systems for the Johns Hopkins Aggregated Diagnosis Groups to Predict Mortality in a General Adult Population Cohort in Ontario, Canada , 2011, Medical care.

[19]  R. Kozak,et al.  Thermal ablation of small renal masses: intermediate outcomes from a Canadian center. , 2011, The Canadian journal of urology.

[20]  Han Yong Choi,et al.  The epidemiology of renal cell carcinoma. , 2011, European urology.

[21]  A. Evans,et al.  Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. , 2011, European urology.

[22]  G. Tomlinson,et al.  The effect of age on the morbidity of kidney surgery. , 2011, The Journal of urology.

[23]  C. Lohse,et al.  Renal nephrometry score is associated with urine leak after partial nephrectomy , 2011, BJU international.

[24]  A. Evans,et al.  Active surveillance of small renal masses: progression patterns of early stage kidney cancer. , 2011, European urology.

[25]  G. Sung,et al.  Comparison of laparoscopic radical nephrectomy and open radical nephrectomy for pathologic stage T1 and T2 renal cell carcinoma with clear cell histologic features: a multi-institutional study. , 2011, Urology.

[26]  Ronald B. Moore,et al.  Adverse renal outcomes in subjects undergoing nephrectomy for renal tumors: a population-based analysis. , 2011, European urology.

[27]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[28]  David C. Miller,et al.  Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study. , 2010, The Journal of urology.

[29]  U. Capitanio,et al.  A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma. , 2010, Urology.

[30]  Lorenzo Marconi,et al.  EAU guidelines on renal cell carcinoma: 2014 update. , 2010, European urology.

[31]  J. McKiernan,et al.  Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis , 2010, BJU international.

[32]  A. Laupacis,et al.  Using Administrative Datasets to Study Outcomes in Dialysis Patients: A Validation Study , 2010, Medical care.

[33]  Chad R. Tracy,et al.  Durable oncologic outcomes after radiofrequency ablation , 2010, Cancer.

[34]  Wong-Ho Chow,et al.  Epidemiology and risk factors for kidney cancer , 2010, Nature Reviews Urology.

[35]  Inderbir S Gill,et al.  Kidney tumor location measurement using the C index method. , 2010, The Journal of urology.

[36]  G. Tomlinson,et al.  Unintended consequences of laparoscopic surgery on partial nephrectomy for kidney cancer. , 2010, The Journal of urology.

[37]  S. Bonsib.  Renal cystic diseases and renal neoplasms: a mini-review. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[38]  P. Russo,et al.  Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. , 2009, The Journal of urology.

[39]  R. Foley,et al.  The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[40]  Walter Artibani,et al.  Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. , 2009, European urology.

[41]  J. Kaouk,et al.  Guideline for management of the clinical T1 renal mass. , 2009, The Journal of urology.

[42]  Robert G Uzzo,et al.  The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. , 2009, The Journal of urology.

[43]  J. Cadeddu,et al.  Radiofrequency ablation of small renal cortical tumours in healthy adults: renal function preservation and intermediate oncological outcome , 2009, BJU international.

[44]  H. Klingler,et al.  Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience. , 2009, European urology.

[45]  I. Derweesh,et al.  Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy , 2009, BJU international.

[46]  P. Russo,et al.  Metastatic renal cell carcinoma risk according to tumor size. , 2009, The Journal of urology.

[47]  F. Saad,et al.  Radical versus partial nephrectomy , 2009, Cancer.

[48]  W. Lowrance,et al.  Adult Urology Oncology : Adrenal / Renal / Upper Tract / Bladder Contemporary Use of Partial Nephrectomy at a Tertiary Care Center in the United States , 2022 .

[49]  R. Foley,et al.  CKD surveillance using administrative data: impact on the health care system. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[50]  D. Albanes,et al.  Body size and renal cell cancer incidence in a large US cohort study. , 2008, American journal of epidemiology.

[51]  P. Dennen,et al.  Long-term outcomes of acute kidney injury. , 2008, Advances in chronic kidney disease.

[52]  C. Morash,et al.  Preservation of renal function following partial or radical nephrectomy using 24-hour creatinine clearance. , 2008, European urology.

[53]  Paul Russo,et al.  Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. , 2008, The Journal of urology.

[54]  Christopher S Saigal,et al.  Diffusion of surgical innovation among patients with kidney cancer , 2008, Cancer.

[55]  Stephanie Daignault,et al.  Hospital Characteristics and Use of Innovative Surgical Therapies Among Patients With Kidney Cancer , 2008, Medical care.

[56]  Stephen A Boorjian,et al.  Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. , 2008, The Journal of urology.

[57]  M. Schonlau,et al.  Renal and cardiovascular morbidity after partial or radical nephrectomy , 2008, Cancer.

[58]  Hude Quan,et al.  Cross-National Comparative Performance of Three Versions of the ICD-10 Charlson Index , 2007, Medical care.

[59]  J. Tu,et al.  ICD-10 adaptations of the Ontario acute myocardial infarction mortality prediction rules performed as well as the original versions. , 2007, Journal of clinical epidemiology.

[60]  Louis R Kavoussi,et al.  Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. , 2007, The Journal of urology.

[61]  D. Lin,et al.  Trends in renal cancer surgery and patient provider characteristics associated with partial nephrectomy in the United States. , 2007, Urologic oncology.

[62]  P Fornara,et al.  Positive margins in laparoscopic partial nephrectomy in 855 cases: a multi-institutional survey from the United States and Europe. , 2007, The Journal of urology.

[63]  R. Sylvester,et al.  A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. , 2007, European urology.

[64]  David McDermott,et al.  Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. , 2007, The New England journal of medicine.

[65]  C. Kane,et al.  Analysis of complications following partial and total nephrectomy for renal cancer in a population based sample. , 2007, The Journal of urology.

[66]  Karen Tu,et al.  Accuracy of administrative databases in identifying patients with hypertension , 2007, Open medicine : a peer-reviewed, independent, open-access journal.

[67]  I. Gill,et al.  Minimally invasive nephron-sparing surgery (MINSS) for renal tumours. Part II: probe ablative therapy. , 2007, European urology.

[68]  R. Figlin,et al.  Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. , 2007, The New England journal of medicine.

[69]  L. Kavoussi,et al.  Positive surgical parenchymal margin after laparoscopic partial nephrectomy for renal cell carcinoma: oncological outcomes. , 2006, The Journal of urology.

[70]  Melania Pintilie,et al.  Competing Risks: A Practical Perspective , 2006 .

[71]  Stephanie Daignault,et al.  Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect , 2006 .

[72]  Andrew J Vickers,et al.  Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. , 2006, The Lancet. Oncology.

[73]  L. Køber,et al.  Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction , 2006, Circulation.

[74]  R. Motzer,et al.  Sunitinib in patients with metastatic renal cell carcinoma. , 2006, JAMA.

[75]  G. Rosner,et al.  Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  David C. Miller,et al.  Partial nephrectomy for small renal masses: an emerging quality of care concern? , 2006, The Journal of urology.

[77]  Til Stürmer,et al.  Indications for propensity scores and review of their use in pharmacoepidemiology. , 2006, Basic & clinical pharmacology & toxicology.

[78]  L. Price,et al.  Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. , 2005, Clinical journal of the American Society of Nephrology : CJASN.

[79]  G. Naglie,et al.  30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. , 2005, Journal of the National Cancer Institute.

[80]  L. Kavoussi,et al.  Long-term survival analysis after laparoscopic radical nephrectomy. , 2005, The Journal of urology.

[81]  L. Kavoussi,et al.  Laparoscopic radical nephrectomy: long-term outcomes. , 2005, Journal of endourology.

[82]  P. Brennan,et al.  Renal cell carcinoma in relation to cigarette smoking: Meta‐analysis of 24 studies , 2005, International journal of cancer.

[83]  Peter C Austin,et al.  Comparison of Coding of Heart Failure and Comorbidities in Administrative and Clinical Data for Use in Outcomes Research , 2005, Medical care.

[84]  Kenneth Pietz,et al.  Comparison of the Predictive Validity of Diagnosis-Based Risk Adjusters for Clinical Outcomes , 2005, Medical care.

[85]  H. Quan,et al.  New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. , 2004, Journal of clinical epidemiology.

[86]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[87]  Li-Ming Su,et al.  Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. , 2004, The Journal of urology.

[88]  M. Gleave,et al.  Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. , 2004, The Journal of urology.

[89]  Jacques Tostain,et al.  Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. , 2004, The Journal of urology.

[90]  Seth M Steinberg,et al.  A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. , 2003, The New England journal of medicine.

[91]  David W. Johnson,et al.  Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[92]  Peter C Austin,et al.  A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. , 2002, American heart journal.

[93]  R. Feise.  Do multiple outcome measures require p-value adjustment? , 2002, BMC medical research methodology.

[94]  Paul Russo,et al.  Natural history of chronic renal insufficiency after partial and radical nephrectomy. , 2002, Urology.

[95]  C. Bokemeyer,et al.  The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience , 2002, BJU international.

[96]  R. Clayman,et al.  Long-term followup after laparoscopic radical nephrectomy. , 2002, The Journal of urology.

[97]  N. Munshi,et al.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. , 2001, The New England journal of medicine.

[98]  A. Belldegrun,et al.  The changing natural history of renal cell carcinoma. , 2001, The Journal of urology.

[99]  R. Sylvester,et al.  Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial , 2001, The Lancet.

[100]  P. Austin,et al.  Long-term MI outcomes at hospitals with or without on-site revascularization. , 2001, JAMA.

[101]  J V Tu,et al.  Development and validation of the Ontario acute myocardial infarction mortality prediction rules. , 2001, Journal of the American College of Cardiology.

[102]  A. Weaver,et al.  Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. , 2000, Mayo Clinic proceedings.

[103]  J. Daley,et al.  Comparison of complications after radical and partial nephrectomy: results from the National Veterans Administration Surgical Quality Improvement Program , 2000, BJU international.

[104]  P. Russo,et al.  Surgical management of renal tumors 4 cm. or less in a contemporary cohort. , 2000, The Journal of urology.

[105]  R. Figlin,et al.  Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies. , 2000, The Journal of urology.

[106]  A. Novick,et al.  Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. , 2000, The Journal of urology.

[107]  A. Novick,et al.  Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. , 1999, The Journal of urology.

[108]  P. Austin,et al.  Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[109]  T. Kälble,et al.  Radical Nephrectomy forRenal Cell Carcinoma:Is Adrenalectomy Necessary? , 1999, European Urology.

[110]  J L Warren,et al.  Rising incidence of renal cell cancer in the United States. , 1999, JAMA.

[111]  C. Bombardier,et al.  Accuracy of administrative data for assessing outcomes after knee replacement surgery. , 1997, Journal of clinical epidemiology.

[112]  P. Rochon,et al.  Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. , 1996, Medical care.

[113]  H. Herr.  Partial nephrectomy for incidental renal cell carcinoma. , 1994, British journal of urology.

[114]  R. Clayman,et al.  Adrenal involvement from renal cell carcinoma: predictive value of computerized tomography. , 1994, The Journal of urology.

[115]  A. Novick,et al.  Nephron sparing surgery in incidental versus suspected renal cell carcinoma. , 1994, The Journal of urology.

[116]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[117]  A. Sigel,et al.  What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma. , 1991, The Journal of urology.

[118]  M. Bosniak,et al.  Partial nephrectomy for renal cell carcinoma: indications, results and implications. , 1991, The Journal of urology.

[119]  Amit X Garg,et al.  Validity of administrative database coding for kidney disease: a systematic review. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[120]  Cancer Forum.  Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Update , 2009 .

[121]  Paul Russo,et al.  Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? , 2009, The Journal of urology.

[122]  P. Russo,et al.  Complications of radical and partial nephrectomy in a large contemporary cohort. , 2004, The Journal of urology.

[123]  M. D'armiento,et al.  Elective conservative surgery for renal carcinoma versus radical nephrectomy: a prospective study. , 1997, British journal of urology.

[124]  M. Blute,et al.  Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. , 1996, The Journal of urology.

[125]  A. Novick,et al.  Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. , 1995, Urology.

[126]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.